Pennsylvania SR 256: A Resolution designating October 13, 2026, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania.
Status: Referred to Rules & Executive Nominations (as of 2026-03-20)
State: Pennsylvania · Session: 2025-2026 · Bill: SR 256
Sponsors: Chris Gebhard, Amanda Cappelletti, Art Haywood, Camera Bartolotta, Carolyn Comitta, Christine Tartaglione, Devlin Robinson, Elder Vogel, Joe Picozzi, John Kane, Judith Schwank, Judy Ward, Kristin Phillips-Hill, Lynda Schlegel Culver, Michele Brooks, Patrick Stefano, Scott Hutchinson, Scott Martin, Tracy Pennycuick, Vincent Hughes, Wayne Fontana
Bill Text
PRINTER'S NO. 1523 THE GENERAL ASSEMBLY OF PENNSYLVANIA SENATE RESOLUTION No. 256 Session of 2026 INTRODUCED BY GEBHARD, BARTOLOTTA, HUGHES, J. WARD, BROOKS, PENNYCUICK, HAYWOOD, MARTIN, TARTAGLIONE, COMITTA, FONTANA, ROBINSON, PHILLIPS-HILL, PICOZZI, CAPPELLETTI, SCHWANK, HUTCHINSON AND VOGEL, MARCH 20, 2026 REFERRED TO RULES AND EXECUTIVE NOMINATIONS, MARCH 20, 2026 A RESOLUTION Designating October 13, 2026, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania. WHEREAS, Breast cancer is the most commonly diagnosed cancer among women worldwide, and metastatic breast cancer (MBC), also known as Stage IV when the disease spreads beyond the breast to other parts of the body, remains incurable and is responsible for nearly all breast cancer deaths; and WHEREAS, Despite advances in early detection and treatment, approximately 30% of early-stage breast cancers will eventually metastasize; and WHEREAS, In 2026, an estimated 324,580 new cases of breast cancer will be diagnosed in the United States, and approximately 42,670 Americans and more than 670,000 people globally will die from breast cancer, the vast majority due to metastatic disease; and WHEREAS, In this Commonwealth, thousands of individuals are diagnosed with breast cancer each year, and many Pennsylvanians 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 are living with MBC, underscoring the urgent need for dedicated research, awareness and equitable access to care across Pennsylvania; and WHEREAS, Despite the devastating impact of MBC, less than 13% of global breast cancer research funding is dedicated specifically to MBC, leaving patients with limited treatment options and families facing devastating outcomes; and WHEREAS, Increased research funding is critical to transforming MBC from a terminal diagnosis into a chronic, survivable condition, offering patients more time, more options and more hope; and WHEREAS, Significant racial and ethnic disparities persist in breast cancer outcomes, with Black women in the United States facing a substantially higher mortality rate than White women and Hispanic women experiencing breast cancer as the leading cause of cancer-related death, inequities that demand urgent action through inclusive research, equitable access to care across urban, suburban and rural communities and culturally responsive education; and WHEREAS, METAvivor Research and Support, a national nonprofit organization exclusively dedicated to funding MBC research, and the global #LightUpMBC campaign elevate awareness, amplify patient voices and honor lives lost by illuminating landmarks across Pennsylvania and around the world each year on October 13 in the tri-color metastatic breast cancer awareness ribbon colors of teal (healing), green (hope) and pink (breast cancer origin); and WHEREAS, This Commonwealth is proud to stand with individuals and families affected by MBC, honoring their courage and resilience while advancing the critical pursuit of research that 20260SR0256PN1523 - 2 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 saves lives; therefore be it RESOLVED, That the House of Representatives designate October 13, 2026, as "Metastatic Breast Cancer Awareness Day" in Pennsylvania. 20260SR0256PN1523 - 3 - 1 2 3 4
View Pennsylvania SR 256 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.